Differential deregulation of astrocytic calcium signalling by amyloid-β, TNFα, IL-1β and LPS

In Alzheimer's disease (AD), astrocytes undergo complex morphological and functional changes that include early atrophy, reactive activation and Ca²⁺ deregulation. Recently, we proposed a mechanism by which nanomolar Aβ₄₂ deregulates mGluR5 and InsP₃ receptors, the key elements of astrocytic Ca²⁺ signalling toolkit. To evaluate the specificity of these changes, we have now investigated whether the effects of Aβ₄₂ on Ca²⁺ signalling machinery can be reproduced by pro-inflammatory agents (TNFα, IL-1β, LPS). Here we report that Aβ₄₂ (100nM, 72h) significantly increased mRNA levels of mGluR5, InsP₃R1 and InsP₃R2, whereas pro-inflammatory agents reduced expression of these specific mRNAs. Furthermore, DHPG-induced Ca²⁺ signals and store operated Ca²⁺ entry (SOCE) were augmented in Aβ₄₂-treated cells due to up-regulation of a set of Ca²⁺ signalling-related genes including TRPC1 and TRPC4. Opposite changes were observed when astrocytes were treated with TNFα, IL-1β and LPS. Last, the effects observed on SOCE by treating wild-type astrocytes with Aβ₄₂ were also identified in untreated astrocytes from 3×Tg-AD animals, suggesting a link to the AD pathology. Our results demonstrate that effects of Aβ₄₂ on astrocytic Ca²⁺ signalling differ from and may contrast to the effects of pro-inflammatory agents.